Citywire - For Professional Investors

Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

Polar Capital’s Pinniger: how to play biotech beyond the US

Biotech is no longer a US-only story and investors can tap an ever-growing range of new ideas in Europe and even further afield.

That is according to David Pinniger, who has added several small-cap European names to his Polar Capital Biotechnology fund since its launch in November 2013.

In this video, Pinniger also addresses market volatility and why the strong risk/reward dynamics don’t look like changing any time soon.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.